Menu

New Nursing Leader Named to Rutgers Cancer Institute of New Jersey and RWJBarnabas Health

November 1, 2019

New Brunswick, N.J., November 1, 2019 – Reaffirming its commitment to continued growth and excellence, and following a national search, Rutgers Cancer Institute of New Jersey and RWJBarnabas Health are pleased to welcome Carolyn Hayes, PhD, RN, NEA-BC, as the new Chief Nursing Officer, RWJBarnabas, Oncology Services and Rutgers Cancer Institute. In these roles, she will be responsible for and have oversight of nursing at Rutgers Cancer Institute and oncology service line-related nursing across RWJBarnabas Health, ensuring nursing excellence throughout an integrated cancer care model.

Dr. Hayes also holds a faculty appointment as an associate professor in the Division of Nursing Science at Rutgers School of Nursing. She most recently served as president and executive director of the Greater Boston Nursing Collective, a cooperative organization devoted to advancing the research, teaching, practice and leadership of integrative nursing.  Her clinical leadership roles have included serving as associate chief of oncology, medical and integrative nursing, as well as associate chief of adult inpatient and integrative oncology nursing at Brigham and Women’s Hospital and Dana-Farber Cancer Institute in Boston.

Hayes has vast experience in ensuring the continuity of care across the ambulatory and acute care continuum for oncology patients in unique collaborative settings, including those that bring together a National Cancer Institute-designated Comprehensive Cancer Center and large health care system in an academic setting. As a nursing leader, Hayes also secured and served as a principal investigator on a more than $4 million philanthropic gift specific to integrative nursing. 

Along with having overseen the expansion of inpatient oncology services and having co-created an intensive palliative care unit while in previous positions, Hayes also was instrumental designing, implementing and evaluating clinical programs and projects in both ambulatory and inpatient care environments. 

“Nursing leadership requires more than advanced clinical expertise. Throughout her career, Dr. Hayes has demonstrated success not only in the development and management of comprehensive patient care, but in the areas of nursing philanthropy, research and teaching as well,” shares Rutgers Cancer Institute Director Steven K. Libutti, MD, FACS, who is also senior vice president of oncology services for RWJBarnabas Health. “Her vast knowledge of the unique, collaborative relationship between an NCI-designated Comprehensive Cancer Center and a large health care system will enhance the position of Rutgers Cancer Institute and RWJBarnabas Health as a leading oncology authority in our state and region. We are pleased to welcome Dr. Hayes to our team.”

“With advances in technology and knowledge, the delivery of oncology nursing is continually changing – but the philosophy of our profession remains the same: ensuring optimal delivery of patient care. In my new roles at Rutgers Cancer Institute and RWJBarnabas Health, I am excited to develop and bring forth opportunities to enhance the development and education of those on our nursing team so that they are best prepared to contribute to the patient experience and outcomes expected of our profession,” notes Hayes.

A member of the American Nurses Association and other professional organizations, Hayes is also an advocate of mentoring and professional development for oncology nurses to advance evidence-based practice. Hayes also presents regularly at national and international nursing and research conferences and is the author of numerous publications including book chapters addressing the nursing profession. 

 

About Rutgers Cancer Institute of New Jersey

As New Jersey’s only National Cancer Institute-designated Comprehensive Cancer Center, Rutgers Cancer Institute, along with its partner RWJBarnabas Health, offers the most advanced cancer treatment options including bone marrow transplantation, proton therapy, CAR T-cell therapy and complex robotic surgery.  Along with clinical trials and novel therapeutics such as precision medicine and immunotherapy – many of which are not widely available – patients have access to these cutting-edge therapies at Rutgers Cancer Institute of New Jersey in New Brunswick, Rutgers Cancer Institute of New Jersey at University Hospital in Newark, as well as through RWJBarnabas Health facilities.

Along with world-class treatment, which is often fueled by on-site research conducted in Rutgers Cancer Institute laboratories, patients and their families also can seek cancer preventative services and education resources throughout the Rutgers Cancer Institute and RWJBarnabas Health footprint statewide. To make a tax-deductible gift to support the Cancer Institute of New Jersey, call 848-932-8013 or visit www.cinj.org/giving.

###

 

For journalists – contact:
Michele Fisher, Public Relations Manager
732-235-9872
michele.fisher@rutgers.edu

For patient appointments/inquiries – contact:
844-CANCER-NJ (844-226-2376)

image that says give now and support cancer research with link to giving page

 

 

 

 

Logo for ScreenNJ program and link to website

 

 

 

 

Robert Wood Johnson Barnabas Health logo with link to Partners page

 

  

 

 

 

Big Ten Cancer Research Consortium

 

 

 

 

Rutgers Health